FSB Premier Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
FSB Premier Wealth Management's NVS Position: Q2 2026 in Review
FSB Premier Wealth Management reduced its Novartis (NVS) stake by 20% in Q2 2026, selling an estimated $515K and leaving 13,534 shares worth $2.12M. The position accounts for 0.6% of the portfolio, ranked #47.
FSB Premier Wealth Management first reported a position in NVS in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.59M in Q1 2026. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- FSB Premier Wealth Management held 13,534 shares of Novartis worth $2.12M as of Q2 2026.
- FSB Premier Wealth Management sold 3,436 Novartis shares in Q2 2026, an estimated $515K.
- Novartis made up 0.6% of FSB Premier Wealth Management's portfolio in Q2 2026, its #47 holding.
- FSB Premier Wealth Management first reported a position in Novartis in Q4 2021 and has held it in 16 quarters since.
- FSB Premier Wealth Management's Novartis position peaked at $2.59M in Q1 2026.
- 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on FSB Premier Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.